Diabetes Mellitus, Type 1

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

TrialNet Pathway to Prevention of T1D

Recruiting
  • Diabetes Mellitus, Type 1
    • Orange, California
    • +21 more
    Feb 18, 2022

    Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)

    Completed
    • Diabetes Mellitus, Type 1
    • AG019 - Low Dose
    • +5 more
    • Birmingham, Alabama
    • +17 more
    Nov 9, 2021

    Diabetes, Type 1 Trial in Minneapolis (Experimental hyperglycemia)

    Recruiting
    • Diabetes Mellitus, Type 1
    • Experimental hyperglycemia
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 25, 2021

    Diabetes, Type 1 Trial in Minneapolis (Experimental hypoglycemia)

    Recruiting
    • Diabetes Mellitus, Type 1
    • Experimental hypoglycemia
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 7, 2021

    Diabetes, Type 1 Trial in Worldwide (Oral Insulin, Placebo)

    Completed
    • Diabetes Mellitus, Type 1
    • Oral Insulin
    • Placebo
    • San Francisco, California
    • +17 more
    Apr 27, 2020

    Diabetes, Type 1 Trial in Canada, United States (Mycophenolate mofeteil (MMF), Daclizumab (DZB), Placebo control for

    Completed
    • Diabetes Mellitus, Type 1
    • Mycophenolate mofeteil (MMF)
    • +3 more
    • Los Angeles, California
    • +10 more
    Apr 27, 2020

    Diabetes, Type 1 Trial in Canada, United States (Parenteral Insulin, Close Observation, Oral Insulin)

    Completed
    • Diabetes Mellitus, Type 1
    • Parenteral Insulin
    • +3 more
    • Los Angeles, California
    • +14 more
    Apr 22, 2020

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • insulin aspart
    • Encino, California
    • +91 more
    Nov 12, 2019

    Diabetes, Type 1 Trial in United States (Nasal Glucagon, Intramuscular Glucagon)

    Completed
    • Diabetes Mellitus, Type 1
    • Nasal Glucagon
    • Intramuscular Glucagon
    • Aurora, Colorado
    • +7 more
    Sep 5, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Mobile, Alabama
    • +190 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Tucson, Arizona
    • +151 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Phoenix, Arizona
    • +154 more
    May 22, 2019

    Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)

    Completed
    • Diabetes Mellitus, Type 1
    • Insulin lispro
    • +4 more
    • Escondido, California
    • +18 more
    Feb 5, 2019

    Diabetes, Diabetes, Type 1 Trial in Canada, United States (inhaled human insulin, insulin detemir, insulin aspart)

    Terminated
    • Diabetes
    • Diabetes Mellitus, Type 1
    • inhaled human insulin
    • +2 more
    • Birmingham, Alabama
    • +95 more
    Sep 3, 2018

    Diabetes, Type 1 Trial in United States (Nasal Glucagon, Intramuscular Glucagon)

    Completed
    • Diabetes Mellitus, Type 1
    • Nasal Glucagon
    • Intramuscular Glucagon
    • Aurora, Colorado
    • +6 more
    Aug 1, 2018

    Diabetes, Type 1 Trial in United States (Placebo, PF-06342674 Dose A, PF-06342674 Dose B)

    Completed
    • Diabetes Mellitus, Type 1
    • Placebo
    • +4 more
    • San Diego, California
    • +20 more
    Oct 27, 2017

    Diabetes, Type 1 Trial in Israel, United States (LY2605541, Insulin glargine)

    Completed
    • Diabetes Mellitus, Type 1
    • Chula Vista, California
    • +12 more
    Mar 17, 2018

    Diabetes, Type 1 Trial in Worldwide (Glargine, LY2605541, Insulin Lispro)

    Completed
    • Diabetes Mellitus, Type 1
    • Concord, California
    • +118 more
    Mar 16, 2018

    Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in United Kingdom, United States (FlorenceM, Medtronic insulin

    Completed
    • Diabetes Mellitus
    • +4 more
    • FlorenceM
    • Medtronic insulin pump 640G
    • Aurora, Colorado
    • +7 more
    Mar 12, 2018

    Diabetes, Type 1 Trial in Canada, United States (Otelixizumab)

    Terminated
    • Diabetes Mellitus, Type 1
    • Birmingham, Alabama
    • +16 more
    Oct 11, 2017

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec/insulin aspart
    • +2 more
    • La Mesa, California
    • +80 more
    Feb 9, 2017

    Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Little Rock, Arkansas
    • +181 more
    Jan 16, 2017

    Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Phoenix, Arizona
    • +119 more
    Dec 15, 2016

    Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin lispro
    • insulin aspart
    • Mobile, Alabama
    • +51 more
    Dec 21, 2016

    Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin human
    • +2 more
    • Birmingham, Alabama
    • +75 more
    Dec 21, 2016